Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 8316

1.

Diagnosis of Constitutional Mismatch Repair-deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.

Bodo S, Colas C, Buhard O, Collura A, Tinat J, Lavoine N, Guilloux A, Chalastanis A, Lafitte P, Coulet F, Buisine MP, Ilencikova D, Ruiz-Ponte C, Kinzel M, Grandjouan S, Brems H, Lejeune S, Blanché H, Wang Q, Caron O, Cabaret O, Svrcek M, Vidaud D, Parfait B, Verloes A, Knappe UJ, Soubrier F, Mortemousque I, Leis A, Auclair-Perrossier J, Frébourg T, Fléjou JF, Entz-Werle N, Leclerc J, Malka D, Cohen-Haguenauer O, Goldberg Y, Gerdes AM, Fedhila F, Mathieu-Dramard M, Hamelin R, Wafaa B, Gauthier-Villars M, Bourdeaut F, Sheridan E, Vasen H, Brugières L, Wimmer K, Muleris M, Duval A; European Consortium “Care for CMMRD” (C4CMMRD).

Gastroenterology. 2015 Jun 24. pii: S0016-5085(15)00872-0. doi: 10.1053/j.gastro.2015.06.013. [Epub ahead of print]

PMID:
26116798
2.

Reconstitution of TGFBR2-Mediated Signaling Causes Upregulation of GDF-15 in HCT116 Colorectal Cancer Cells.

Lee J, Fricke F, Warnken U, Schnölzer M, Kopitz J, Gebert J.

PLoS One. 2015 Jun 26;10(6):e0131506. doi: 10.1371/journal.pone.0131506. eCollection 2015.

3.

A novel method for screening colorectal cancer by infrared spectroscopy of peripheral blood mononuclear cells and plasma.

Barlev E, Zelig U, Bar O, Segev C, Mordechai S, Kapelushnik J, Nathan I, Flomen F, Kashtan H, Dickman R, Madhala-Givon O, Wasserberg N.

J Gastroenterol. 2015 Jun 26. [Epub ahead of print]

PMID:
26112122
4.

γ-Glutamyltransferase and cancer risk: the Korean Cancer Prevention Study.

Mok Y, Son DK, Duk Yun Y, Jee SH, Samet JM.

Int J Cancer. 2015 Jun 25. doi: 10.1002/ijc.29659. [Epub ahead of print]

PMID:
26111622
5.

Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths.

Geurts SM, Massat NJ, Duffy SW.

Br J Cancer. 2015 Jun 25. doi: 10.1038/bjc.2015.76. [Epub ahead of print]

PMID:
26110973
6.

Epidemioclinical Feature of Early-Onset Colorectal Cancer at-Risk for Lynch Syndrome in Central Iran.

Zeinalian M, Hashemzadeh-Chaleshtori M, Akbarpour MJ, Emami MH.

Asian Pac J Cancer Prev. 2015;16(11):4647-52.

7.

Colorectal Cancer Biomarkers: Where Are We Now?

Gonzalez-Pons M, Cruz-Correa M.

Biomed Res Int. 2015;2015:149014. doi: 10.1155/2015/149014. Epub 2015 May 27. Review.

8.

Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer.

Jia J, Zheng X, Chen Y, Wang L, Lin L, Ye X, Chen Y, Chen D, Dettke M.

Tumour Biol. 2015 Jun 25. [Epub ahead of print]

PMID:
26104767
9.

Circulating Cell-Free Tumour DNA in the Management of Cancer.

Francis G, Stein S.

Int J Mol Sci. 2015 Jun 19;16(6):14122-42. doi: 10.3390/ijms160614122. Review.

10.

Symptom perceptions and help-seeking behaviour prior to lung and colorectal cancer diagnoses: a qualitative study.

McLachlan S, Mansell G, Sanders T, Yardley S, van der Windt D, Brindle L, Chew-Graham C, Little P.

Fam Pract. 2015 Jun 22. pii: cmv048. [Epub ahead of print]

11.

Alcohol Consumption, Depression, Insomnia and Colorectal Cancer Screening: Racial Differences.

Owusu D, Quinn M, Wang KS.

Int J High Risk Behav Addict. 2015 Jun 20;4(2):e23424. doi: 10.5812/ijhrba.4(2)2015.23424. eCollection 2015 Jun.

12.

Impact of the United Kingdom National Bowel Cancer Awareness Programme 2012 on colorectal cancer services and patient survival.

Khong TL, Naik K, Sivakumar R, Shah S.

Colorectal Dis. 2015 Jun 20. doi: 10.1111/codi.13038. [Epub ahead of print]

PMID:
26096269
13.

Humanized anti-hepatocyte growth factor (HGF) antibody suppresses innate irinotecan (CPT-11) resistance induced by fibroblast-derived HGF.

Woo JK, Kang JH, Kim B, Park BH, Shin KJ, Song SW, Kim JJ, Kim HM, Lee SJ, Oh SH.

Oncotarget. 2015 Jun 8. [Epub ahead of print]

14.

Germline <i>TP53</i> Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.

Yurgelun MB, Masciari S, Joshi VA, Mercado RC, Lindor NM, Gallinger S, Hopper JL, Jenkins MA, Buchanan DD, Newcomb PA, Potter JD, Haile RW, Kucherlapati R, Syngal S; Colon Cancer Family Registry.

JAMA Oncol. 2015 May 1;1(2). doi: 10.1001/jamaoncol.2015.0197.

PMID:
26086041
15.

Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model.

Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Jensen CD, van der Meulen MP, Levin TR, Quinn VP, Schottinger JE, Zauber AG, Corley DA, van Ballegooijen M.

JAMA. 2015 Jun 16;313(23):2349-58. doi: 10.1001/jama.2015.6251.

PMID:
26080339
16.

Cancer survival differences between South Asians and non-South Asians of England in 1986-2004, accounting for age at diagnosis and deprivation.

Maringe C, Li R, Mangtani P, Coleman MP, Rachet B.

Br J Cancer. 2015 Jun 16. doi: 10.1038/bjc.2015.182. [Epub ahead of print]

PMID:
26079299
17.

Advances in the study of Lynch syndrome in China.

Lu JY, Sheng JQ.

World J Gastroenterol. 2015 Jun 14;21(22):6861-6871. Review.

18.

Predictive Levels of CD24 in Peripheral Blood Leukocytes for the Early Detection of Colorectal Adenomas and Adenocarcinomas.

Kraus S, Shapira S, Kazanov D, Naumov I, Moshkowitz M, Santo E, Galazan L, Geva R, Shmueli E, Hallack A, Arber N.

Dis Markers. 2015;2015:916098. doi: 10.1155/2015/916098. Epub 2015 May 11.

19.

Double immunohistochemistry enhances detection of lymphatic and venous invasion in early-stage colorectal cancer.

Ervine AJ, McBride HA, Kelly PJ, Loughrey MB.

Virchows Arch. 2015 Jun 16. [Epub ahead of print]

PMID:
26077465
20.

An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.

Weng W, Feng J, Qin H, Ma Y, Goel A.

Future Oncol. 2015 Jun;11(12):1791-808. doi: 10.2217/fon.15.83.

PMID:
26075447
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk